Company Directory > Biotech > Empresa de Laboratorios AICA
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Empresa de Laboratorios AICA and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Empresa de Laboratorios AICA is a prominent Cuban pharmaceutical company and a subsidiary of the state-owned group BioCubaFarma. The company specializes in the research, development, production, and distribution of sterile medications, including injectables, lyophilized products, ophthalmic solutions, and dental cartridges. It plays a critical role in the Cuban national health system, supplying a significant portion of the country's basic drug formulary. Beyond its core manufacturing capabilities, AICA has been involved in high-profile national health initiatives, including the production of COVID-19 vaccines (such as Abdala) and other essential medical supplies. The company operates multiple production facilities in Havana and holds various quality certifications, including ISO 9001 and GMP compliance, aiming to maintain standards for both domestic supply and international export.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generic drugs, sterile injectables, vaccines
SIZE & FINANCIALS
Employees:1001-5000
Ownership:government
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Vaccines
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:BioCubaFarma
Key Partnerships:BioCubaFarma (Parent group), CECMED (Regulatory oversight)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Antonio Emilio Vallín García - General Director
LINKS
Website:aica.cu
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Empresa de Laboratorios AICA. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.